Crossmark

Voclosporin promotes neurological function recovery by inhibiting inflammation and maintaining blood–brain barrier integrity following rtPA reperfusion after MCAO in mice

Crossref DOI link: https://doi.org/10.1007/s10787-025-01757-3

Published Online: 2025-04-24

Published Print: 2025-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zheng, Yangmin

Ma, Shubei https://orcid.org/0000-0003-4464-2163
Sun, Wei

Yan, Feng

Luo, Yumin
Funding

Funding for this research was provided by:

Dalian Municipal Health Commission’s Peak Climbing Plan Project (2022ZZ202)
License Information

Text and Data Mining valid from 2025-04-24

Version of Record valid from 2025-04-24
More Information

Article History

Received: 25 February 2025

Accepted: 11 April 2025

First Online: 24 April 2025

Declarations

:

: The authors declare no conflict of interest.

: All animal experiments were approved by the Institutional Animal Care and Use Committee of Xuanwu Hospital of Capital Medical University following the Guide for the Care and Use of Laboratory Animals (The application reference number is XW-20220613-1 and the approval date is June 13, 2022).

Document is current

Any future updates will be listed below